Karin Klooster
Overview
Explore the profile of Karin Klooster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klooster K, Bakker J, Hartman J, Slebos D
Arch Bronconeumol
. 2025 Feb;
PMID: 40011112
No abstract available.
2.
Hartman J, Bakker J, Roodenburg S, Klooster K, Slebos D
Lung
. 2025 Jan;
203(1):21.
PMID: 39755853
No abstract available.
3.
Ter Haar E, Slebos D, Klooster K, Pouwels S, Hartman J
ERJ Open Res
. 2024 Nov;
10(6).
PMID: 39559450
Rationale And Aim: Patients with COPD often present with a significant number of comorbidities, which are thought to be related to a higher mortality risk. Our aim was to investigate...
4.
Bakker J, Hartman J, Klooster K, Charbonnier J, Tsiaousis M, Vliegenthart R, et al.
Respir Med
. 2024 Nov;
234:107856.
PMID: 39515624
This study investigated the impact of bronchoscopic lung volume reduction treatment using endobronchial valves (EBV) on diaphragm configuration. We successfully analyzed the diaphragm index using a newly developed quantitative computed...
5.
Bakker J, Dudurych I, Roodenburg S, Vonk J, Klooster K, De Bruijne M, et al.
Eur Radiol
. 2024 Oct;
PMID: 39414656
Introduction: Lung hyperinflation, a key contributor to dyspnea in chronic obstructive pulmonary disease (COPD), can be quantified via chest computed tomography (CT). Establishing reference equations for lobar volumes and total...
6.
Roodenburg S, van Dijk M, Augustijn S, Klooster K, Slebos D, Hartman J
ERJ Open Res
. 2024 Oct;
10(3).
PMID: 39371297
Background: Assessment of static hyperinflation severity is crucial to identify COPD patients eligible for lung volume reduction. The current recommendation of residual volume ≥175% predicted may need to be reconsidered...
7.
Roodenburg S, Klooster K, Hartman J, Kontogianni K, Brock J, Dittrich A, et al.
Respiration
. 2024 Sep;
104(1):58-68.
PMID: 39284292
Introduction: Currently, there is a lack of bronchoscopic lung volume reduction options that do not depend on fissure integrity. Endobronchial coils have been extensively studied to address this need but...
8.
Bakker J, Hartman J, Klooster K, Lynch D, van der Molen M, Charbonnier J, et al.
Eur Radiol Exp
. 2024 Aug;
8(1):87.
PMID: 39090324
Background: Severe chronic obstructive pulmonary disease (COPD) often results in hyperinflation and flattening of the diaphragm. An automated computed tomography (CT)-based tool for quantifying diaphragm configuration, a biomarker for COPD,...
9.
van Dijk M, Van De Wauwer C, Koster T, Klooster K, Slebos D
Interdiscip Cardiovasc Thorac Surg
. 2024 May;
38(5).
PMID: 38724230
Objectives: Bronchoscopic lung volume reduction with endobronchial valves is a guideline treatment leading to improved pulmonary function, exercise tolerance and quality of life, in patients with advanced emphysema, severe hyperinflation...
10.
van Pel R, Gan T, Daniels J, Ruigrok D, Hellemons M, Klooster K, et al.
Clin Transplant
. 2024 Mar;
38(3):e15289.
PMID: 38486062
Introduction: Treatment of post lung-transplant airway complications is challenging, and treatment with conventional airway stents is associated with adverse events. More recently, biodegradable airway stents (BDS) have been introduced and...